CHRNE and congenital myasthenic syndrome: Family 1 presents with a CHRNE-variant (NM_000080.4:c.452_454delAGG, p.(Glu151del)) and a phenotype compatible with CHRNE-related CMS including response to therapy with pyridostigmine and 3,4 DAP.